chr1-119726897-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_006623.4(PHGDH):c.403C>T(p.Arg135Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,461,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R135G) has been classified as Uncertain significance.
Frequency
Consequence
NM_006623.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251476Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135914
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461640Hom.: 0 Cov.: 30 AF XY: 0.0000179 AC XY: 13AN XY: 727134
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PHGDH deficiency Pathogenic:2
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 135 of the PHGDH protein (p.Arg135Trp). This variant is present in population databases (rs267606949, gnomAD 0.006%). This missense change has been observed in individual(s) with PHGDH-related conditions (PMID: 19235232, 22886422, 26610677). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 3870). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PHGDH protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:2
Reported previously in two unrelated patients with congenital microcephaly, seizures, and severely reduced L-serine in CSF, who also harbored a second variant in PHGDH, phase unknown (PMID: 19235232, 26610677); Published functional studies demonstrate a damaging effect and show that this variant decreases PHGDH enzyme activity (PMID: 19235232, 33753166); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24836451, 33753166, 19235232, 19963421, 26610677, 32594192, 27959531) -
- -
PHGDH deficiency;C4551478:Neu-Laxova syndrome 1 Pathogenic:1Uncertain:1
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at